That's tame. It's a valid point that NWBO received PIM in Sept and still has not been approved for EAM yet Keytruda received PIM in Oct and is approved first.
And almost a decade later we still have longs hyping the PIM designation and ignoring the lack of EAMS designation to allow commercial marketing while waiting for MHRA.